Victrex plc (LON:VCT - Get Free Report) shares fell 8.4% during mid-day trading on Tuesday . The stock traded as low as GBX 667.62 ($9.07) and last traded at GBX 720 ($9.78). 827,259 shares changed hands during mid-day trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.68).
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. JPMorgan Chase & Co. decreased their target price on shares of Victrex from GBX 940 ($12.77) to GBX 818 ($11.11) and set a "neutral" rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft cut shares of Victrex to a "hold" rating and decreased their target price for the stock from GBX 990 ($13.45) to GBX 850 ($11.55) in a report on Tuesday.
Check Out Our Latest Research Report on Victrex
Victrex Stock Performance
The stock has a market cap of £631.91 million, a P/E ratio of 20.58, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69. The firm's 50-day moving average is GBX 795.78 and its two-hundred day moving average is GBX 890.75. The company has a quick ratio of 1.99, a current ratio of 4.39 and a debt-to-equity ratio of 10.93.
Victrex (LON:VCT - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) EPS for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. As a group, research analysts expect that Victrex plc will post 73.1078905 EPS for the current year.
Insiders Place Their Bets
In other news, insider Dame Vivienne Cox bought 2,747 shares of Victrex stock in a transaction dated Tuesday, July 8th. The shares were bought at an average price of GBX 721 ($9.79) per share, for a total transaction of £19,805.87 ($26,906.49). Also, insider David Thomas bought 1,158 shares of Victrex stock in a transaction dated Tuesday, May 13th. The stock was purchased at an average price of GBX 846 ($11.49) per share, for a total transaction of £9,796.68 ($13,308.90). 1.64% of the stock is owned by insiders.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Further Reading
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
